Nephro Care India Limited’s (IPO) opens on June 28, 2024, and closes on July 2, 2024. The allotment for the Nephro Care India IPO is anticipated to be completed on Wednesday, July 3, 2024. The IPO will be listed on the NSE and SME, with a tentative listing date set for Friday, July 5, 2024.

The price band for the Nephro Care India IPO is set at Rs 85 to 90 per share. The IPO is a book-built issue of Rs 41.26 crores, entirely a fresh issue of 45.84 lakh shares.

Nephro Care India IPO Details

IPO DateJune 28, 2024 to July 2, 2024
Listing Date[.]
Face ValueRs 10 per share
PriceRs 85 to Rs 90 per share
Lot Size1600 Shares
Total Issue Size4,584,000 shares
(aggregating up to Rs 41.26 Cr)
Fresh Issue4,584,000 shares
(aggregating up to Rs 41.26 Cr)
Issue TypeBook Built Issue IPO
Listing AtNSE SM
Shareholding pre issue11,902,400
Shareholding post issue16,486,400
Market Maker portion230,400 share

Nephro Care India IPO Lot Size

Retail (Min)11600Rs 144,000
Retail (Max)11600Rs 144,000
S-HNI (Min)23,200Rs 288,000

Nephro Care India Objective

The objectives of the Issue are:

  1. NCIL intends to utilize Rs 26.17 crore of net proceeds from the IPO to set up a multi-specialist healthcare facility, Vivacity Multi Specialist Hospital, at Madhyamgram in Kolkata.
  2. The remaining capital for general corporate purposes.

About Nephro Care India Limited Company

Nephro Care India, founded in 2014 in Kolkata, offers medical services for renal patients. It is a treatment center providing clinical and lifestyle solutions for renal insufficiency.

Supported by expert doctors, experienced paramedical professionals, and a skilled management team, Nephro Care India Ltd currently employs 110 personnel. As of today, the clinical center provides healthcare services to more than 900 Chronic Kidney Disease patients each month. Their principal facility, located in Salt Lake, Kolkata, covers an area of 5,352 square feet and is complemented by three additional satellite clinics in Kolkata and other parts of West Bengal.

Nephro Care India Limited Financial Information

Nephro Care India Limited’s revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Dec 202331 Mar 202331 Mar 202231 Mar 2021
Profit After Tax340.04194.24-0.988.87
Net Worth1,392.32243.7649.521.50
Reserves and Surplus1,332.81193.760.480.50
Total Borrowing246.39253.7469.27

Nephro Care India IPO Timeline

IPO Open DateFriday, June 28, 2024
IPO Close DateTuesday, July 2, 2024
Basis of AllotmentWednesday, July 3, 2024
Initiation of RefundsThursday, July 4, 2024
Credit of Shares to DematThursday, July 4, 2024
Listing DateFriday, July 5, 2024
Cut-off time for UPI mandate confirmation5 PM on July 2, 2024


Nephro Care India Limited’s IPO presents a promising opportunity for investors, with the issue opening on June 28, 2024, and closing on July 2, 2024. The IPO, priced between Rs 85 to 90 per share, aims to raise Rs 41.26 crores through the issuance of 4.584 million shares. The company has shown significant financial growth, with a revenue increase of 398.84% and a substantial rise in profit after tax. The funds raised will support the establishment of a multi-speciality healthcare facility in Kolkata, enhancing their service offerings for renal patients. With the listing set for July 5, 2024, on NSE SME, Nephro Care India Limited’s IPO is a noteworthy consideration for potential investors

Write A Comment